|
|
|
| |
|
|
| |
The latest breast cancer news from News Medical |
|
|
|
 | | |  How soy and gut microbes alter cancer treatment results Researchers have discovered that plant-derived phytochemicals and their gut microbiome metabolites control the effectiveness of PI3K inhibitors in cancer therapy. The study reveals that dietary components, especially soy compounds processed by gut bacteria, can alter drug metabolism and impact treatment outcomes. | | | | |  Is olive oil good for you? Evidence-based health effects explained Olive oil, especially extra virgin, is a cornerstone of the Mediterranean diet and is associated with reduced risks of cardiovascular disease, cancer, metabolic syndrome, and cognitive decline. Extensive research highlights its anti-inflammatory, antioxidant, and metabolic benefits, while emphasizing the importance of authenticity and accessibility for public health. | |
|
|
| | | | |  As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a new study sheds light on whether patients are opting for it. | | | | |  Switching to camizestrant, a next-generation oral SERD, significantly prolongs progression-free survival and maintains quality of life in patients with ESR1-mutated, hormone receptor-positive advanced breast cancer. The proactive, biomarker-guided approach allows earlier intervention and may redefine standard care. | | | | |  Patients with Stage II and III (early-stage) HER2+ breast cancer usually undergo pre-operative therapy with multi-agent chemotherapy in combination with anti-HER2 antibodies, followed by surgery. | | | | |  A recent randomized controlled trial assessed the benefits of a group-based intervention that fosters communication and coping skills in a culturally tailored way for Latina breast cancer survivors and their caregivers. | | | | |  Recent advances in cancer research have underscored the critical role of myeloid cells in shaping tumor microenvironments (TME), influencing tumor progression, immune evasion, and therapeutic resistance. | | | | |  Cancer cell movement during metastasis is a dynamic process regulated by several different signals. However, the way cells receive, process and respond to these signals has been extremely hard to detect, but is now made easier by a new visualisation tool. | | | | |  The prestigious journal Hepatology Communications reports on the discovery by the Cancer and Translational Medicine research group of the University of the Basque Country (EHU). | | | | |  B lymphocytes exhibit dual roles in tumorigenesis, acting as both allies and adversaries in the tumor microenvironment (TME). | | | | |  In a comprehensive Genomic Press Interview published today, Dr. Stephen Ross, a leading figure in psychedelic medicine at New York University (NYU), reveals how a serendipitous conversation in 2006 launched his journey into investigating psychedelic compounds as potential breakthrough treatments for some of psychiatry's most challenging conditions. | | | | |  Patients with womb cancer are not being tested for a genetic condition that increases their chance of developing further cancers, a study has found. | |
|
|
|
|
|
|
|
